日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Margetuximab 与 Trastuzumab 治疗既往接受过治疗的 HER2 阳性晚期乳腺癌患者(SOPHIA):一项随机 3 期试验的最终总生存期结果

Rugo, Hope S; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D; Bachelot, Thomas; Wright, Gail S; Saura, Cristina; Escrivá-de-Romaní, Santiago; De Laurentiis, Michelino; Schwartz, Gary N; Pluard, Timothy J; Ricci, Francesco; Gwin, William R 3rd; Levy, Christelle; Brown-Glaberman, Ursa; Ferrero, Jean-Marc; de Boer, Maaike; Kim, Sung-Bae; Petráková, Katarína; Yardley, Denise A; Freedman, Orit; Jakobsen, Erik H; Gal-Yam, Einav Nili; Yerushalmi, Rinat; Fasching, Peter A; Kaufman, Peter A; Ashley, Emily J; Perez-Olle, Raul; Hong, Shengyan; Rosales, Minori Koshiji; Gradishar, William J

Role of Fcγ receptors in HER2-targeted breast cancer therapy

Fcγ受体在HER2靶向乳腺癌治疗中的作用

Musolino, Antonino; Gradishar, William J; Rugo, Hope S; Nordstrom, Jeffrey L; Rock, Edwin P; Arnaldez, Fernanda; Pegram, Mark D

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial

Margetuximab 与 Trastuzumab 治疗既往接受过治疗的 ERBB2 阳性晚期乳腺癌患者的疗效比较:一项 3 期随机临床试验

Rugo, Hope S; Im, Seock-Ah; Cardoso, Fatima; Cortés, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D; Wright, Gail S; Saura, Cristina; Escrivá-de-Romaní, Santiago; De Laurentiis, Michelino; Levy, Christelle; Brown-Glaberman, Ursa; Ferrero, Jean-Marc; de Boer, Maaike; Kim, Sung-Bae; Petráková, Katarína; Yardley, Denise A; Freedman, Orit; Jakobsen, Erik H; Kaufman, Bella; Yerushalmi, Rinat; Fasching, Peter A; Nordstrom, Jeffrey L; Bonvini, Ezio; Koenig, Scott; Edlich, Sutton; Hong, Shengyan; Rock, Edwin P; Gradishar, William J

Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance

CD47阻断剂与曲妥珠单抗联合使用可清除HER2阳性乳腺癌细胞并克服曲妥珠单抗耐药性。

Upton, Rosalynd; Banuelos, Allison; Feng, Dongdong; Biswas, Tanuka; Kao, Kevin; McKenna, Kelly; Willingham, Stephen; Ho, Po Yi; Rosental, Benyamin; Tal, Michal Caspi; Raveh, Tal; Volkmer, Jens-Peter; Pegram, Mark D; Weissman, Irving L

First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

首次人体I期剂量递增研究,评估双侧抗HER2抗体药物偶联物MEDI4276在HER2阳性晚期乳腺癌或胃癌患者中的疗效

Pegram, Mark D; Hamilton, Erika P; Tan, Antoinette R; Storniolo, Anna Maria; Balic, Kemal; Rosenbaum, Anton I; Liang, Meina; He, Peng; Marshall, Shannon; Scheuber, Anita; Das, Mayukh; Patel, Manish R

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

抗CD47抗体Hu5F9-G4在晚期癌症患者中开展的首个人体、同类首创的I期临床试验

Sikic, Branimir I; Lakhani, Nehal; Patnaik, Amita; Shah, Sumit A; Chandana, Sreenivasa R; Rasco, Drew; Colevas, A Dimitrios; O'Rourke, Timothy; Narayanan, Sujata; Papadopoulos, Kyriakos; Fisher, George A; Villalobos, Victor; Prohaska, Susan S; Howard, Maureen; Beeram, Muralidhar; Chao, Mark P; Agoram, Balaji; Chen, James Y; Huang, Jie; Axt, Matthew; Liu, Jie; Volkmer, Jens-Peter; Majeti, Ravindra; Weissman, Irving L; Takimoto, Chris H; Supan, Dana; Wakelee, Heather A; Aoki, Rhonda; Pegram, Mark D; Padda, Sukhmani K

PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study

PF-05280014(曲妥珠单抗生物类似药)联合紫杉醇与参考曲妥珠单抗联合紫杉醇治疗HER2阳性转移性乳腺癌的疗效比较:一项随机、双盲研究

Pegram, Mark D; Bondarenko, Igor; Zorzetto, Marina Moreira Costa; Hingmire, Sachin; Iwase, Hirotaka; Krivorotko, Petr V; Lee, Keun Seok; Li, Rubi K; Pikiel, Joanna; Aggarwal, Rajesh; Ewesuedo, Reginald; Freyman, Amy; Li, Ray; Vana, Alicia; Yin, Donghua; Zacharchuk, Charles; Tan-Chiu, Elizabeth

Induced pluripotent stem cells as a novel cancer vaccine

诱导多能干细胞作为一种新型癌症疫苗

Wang, Lin; Pegram, Mark D; Wu, Joseph C

Hydrogel Pore-Size Modulation for Enhanced Single-Cell Western Blotting.

水凝胶孔径调控增强单细胞蛋白质印迹分析

Duncombe Todd A, Kang Chi-Chih, Maity Santanu, Ward Toby M, Pegram Mark D, Murthy Niren, Herr Amy E

Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology

利用超高通量微流控涡旋技术分离的大型循环肿瘤细胞的分类

Che, James; Yu, Victor; Dhar, Manjima; Renier, Corinne; Matsumoto, Melissa; Heirich, Kyra; Garon, Edward B; Goldman, Jonathan; Rao, Jianyu; Sledge, George W; Pegram, Mark D; Sheth, Shruti; Jeffrey, Stefanie S; Kulkarni, Rajan P; Sollier, Elodie; Di Carlo, Dino